Table 1 Clinical symptoms and ESSDAI items of sicca-positive and -negative patients at baseline
Clinical symptoms at first visit | Initial ESSDAI | |||
|---|---|---|---|---|
All patients (n = 31) | Sicca (+) (n = 9) | Sicca (−) (n = 22) | (12 domains) | |
Glandular involvement | 15 (48.4%) | |||
Sicca symptoms | 9 (29.0%) | 9 | 0 | |
Recurrent parotitis (glandular) | 9 (29.0%) | 3 | 6 | 10 (32.3%) |
Extraglandular symptoms | 29 (93.5%) | 9 | 20 | |
Constitutional (fever) | 19 (61.3%) | 5 | 14 | 18 (58.1%) |
Lymphadenopathy | 7 (22.6%) | 1 | 6 | 9 (29.0%) |
Arthritis/arthralgia | 14 (45.2%) | 4 | 10 | 9 (29.0%) |
Cutaneous (annular erythema) | 7 (22.6%) | 3 | 4 | 9 (29.0%) |
Cutaneous (purpura) | 6 (19.4%) | 4 | 2 | |
Peripheral neurologic symptoms | 1 (3.2%) | 1 | 0 | 2 (6.5%) |
Central nervous system symptoms | 1 (3.2%) | 1 | 0 | 3 (9.7%) |
Raynaud’s symptoms | 5 (16.1%) | 2 | 3 | |
General fatigue | 13 (41.9%) | 3 | 10 | |
Symptoms/data of other ESSDAI domains | ||||
Pulmonary | 0 (0%) | 0 | 0 | 0 (0%) |
Renal | 0 (0%) | 0 | 0 | 1 (3.2%) |
Muscle | 0 (0%) | 0 | 0 | 0 (0%) |
Hematological | 3 (9.7%) | |||
Biological | 18 (58.1%) | |||